Lataa...
Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel Diseases
BACKGROUND AND AIMS: Methotrexate [MTX] is a well-known immunomodulator in the treatment of inflammatory bowel disease [IBD] and is often combined with biologic agents. The ideal MTX dose for combination therapy has not been determined. This study aimed to investigate the effect of varying doses of...
Tallennettuna:
| Julkaisussa: | J Crohns Colitis |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6692531/ https://ncbi.nlm.nih.gov/pubmed/30888405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjz020 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|